News and Analysis
Direct lenders back Worldwide Clinical buyout at mid-6x leverage
- David Brooke
- +Will Caiger-Smith
•2 min read
Kohlberg & Company has inked a deal to acquire pharmaceutical research provider Worldwide Clinical Trials at a roughly $2bn valuation, with debt financing from a group of direct lenders led by Blue Owl, according to 9fin sources.